Search - tctmd.com

Displaying 81 - 100 of 105

Sort: Relevancy | Date

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

Presentation CIT 2018

FFR Guided PCI in STEMI patients with Multivessel Disease

Presenter: Pieter C. Smits

March 23, 2018

Presentation CHIP at ACC 2018

Multivessel Disease With A Left Main Equivalent

Presenter: Binita Shah

March 09, 2018

News Daily News

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

Todd Neale

February 21, 2018

News Daily News

The Biggest News of 2017: TCTMD’s Top 10

Shelley Wood

January 01, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

Shelley Wood

December 28, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2017

Shelley Wood

November 29, 2017

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Conference News ACC 2017

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

Todd Neale

March 18, 2017

News Daily News

Rate of Incomplete Revascularization During PCI Is Highly Variable Across Operators

Todd Neale

February 15, 2017

News Daily News

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

L.A. McKeown

January 09, 2017

News Conference News AHA 2016

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

Michael O'Riordan

November 14, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

News Conference News TCT 2016

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

Michael O'Riordan

October 29, 2016

Presentation Stanford Coronary Physiology Conference 2016

FFR in Multivessel Disease: FAME-1 and Substudies

Presenter: Nico H. J. Pijls

October 28, 2016

News Daily News

CTA Can Help Identify True CTOs

August 18, 2015

Advertisement

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

FFR Guided PCI in STEMI patients with Multivessel Disease

Multivessel Disease With A Left Main Equivalent

Routine Use of FFR, iFR Changes Treatment Plans, Even in Patients With Multivessel Disease

The Biggest News of 2017: TCTMD’s Top 10

TCTMD’s Top 10 Most Popular Stories for December 2017

TCTMD’s Top 10 Most Popular Stories for November 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

Rate of Incomplete Revascularization During PCI Is Highly Variable Across Operators

Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains

Shaky FUTURE? FFR Takes a Hit With Mortality Signal in French Study

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients

FFR in Multivessel Disease: FAME-1 and Substudies

CTA Can Help Identify True CTOs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content